New Arizona Proteomics Consortium announced

The University of Arizona has announced the formation of its Arizona Proteomics Consortium, a collaborative effort that pulls together UA proteomics facilities from BIO5, Arizona Cancer Center, Arizona Research Laboratories, department of chemistry, and Southwest Environmental Health Sciences Center.

Proteomics is the study of proteins encoded by the approximately 35,000 genes found in the human genome. This field of study is believed to be essential to the future of personalized medicine, which aims to tailor drugs to patients based upon individual genetic factors.

The new Arizona Proteomics Consortium at UA is one of the few universities in the United States with the highly specialized capabilities for proteomics research and services.

"The University of Arizona is one of the country's leading research universities and the new proteomics consortium is a great example of why we rank so high," said BIO5 Director Vicki Chandler. "By providing this level of proteomics research and service to university and industry investigators, we are contributing to advances in healthcare that will benefit Arizonans and many others."

The new consortium represents Arizona's largest and most comprehensive proteomic service, providing assistance to researchers from academic and private sectors in southern Arizona, the Phoenix metropolitan area, Flagstaff, and nationally.

---

For more information:

"New Arizona Proteomics Consortium brings personalized medicine a few steps closer," BIO5 press release, 07/10/2006